News | December 29, 2009

Cardiovascular MR Differentiates Ischemic, Non-Ischemic Injuries

Cardiovascular magnetic resonance (CMR) study.

December 29, 2009 - In patients with known or suspected myocardial infarction, cardiovascular magnetic resonance (CMR) provides a comprehensive, multifaceted view of the heart, according to a study published in the Dec. 29, 2009 to Jan. 5, 2010 issue of Journal of the American College of Cardiology.

Kim and colleagues review the data, which indicate that delayed enhancement (DE)-CMR is a well-validated, robust technique. Because DE-CMR can differentiate between ischemic and various nonischemic forms of myocardial injury, it is especially useful when there is diagnostic uncertainty. Furthermore, CMR provides clinically relevant information, such as residual viability, microvascular damage, stunning, and right ventricular infarction. Because quantification of infarct size by DE-CMR is highly reproducible, it may provide a useful surrogate end point for clinical trials.

Source: Kim, H.; Farzaneh-Far, A.; Kim, R. "Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications." Journal of the American College of Cardiology. Dec. 29, 2009/Jan. 5, 2010. Vol. 55, No. 1

For more information: content.onlinejacc.org

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...